怡春院免费视频,欧美一级A片在免费看,久久大鸡吧,韩国操逼网,亚洲天堂999,五月天av网,重游母亲桃花源,色婷婷一区二区三区四区成人

^{<dl id="ilis8"></dl>}<strike id="ilis8"><option id="ilis8"></option></strike>

<blockquote id="ilis8"></blockquote>

產(chǎn)品基本信息

產(chǎn)品編號：V758200

產(chǎn)品名稱：Vorapaxar Sulfate

產(chǎn)品CAS：705260-08-8

規(guī)格含量：50mg

產(chǎn)品價格：面議

聯(lián)系我們:

產(chǎn)品詳細(xì)介紹

標(biāo)準(zhǔn)品編號:	V758200
名稱:	Vorapaxar Sulfate
別名:	N-[(1R,3aR,4aR,6R,8aR,9S,9aS)-9-[(1E)-2-[5-(3-Fluorophenyl)-2-pyridinyl]ethenyl]dodecahydro-1-methyl-3-oxonaphtho[2,3-c]furan-6-yl]carbamic Acid Ethyl Ester Sulfate;Sch 530348;
CAS號:	705260-08-8
參考CAS號:	618385-01-6-free base
分子式:	C??H??FN?O?S
外觀:	白色固體
熔點:	>199ºC (dec.)
分子量:	590.66
儲存:	Hygroscopic, 冰箱, under inert atmosphere
溶解度:	Acetonitrile (Very Slightly, Heated), Methanol (Slightly)
類別:	Standards; Chiral Molecules; Pharmaceutical/API Drug Impurities/Metabolites;
應(yīng)用:	SCH-530348 is a novel antiplatelet agent undergoing development by Schering-Plough Corp for the treatment and prevention of atherothrombosis. It is currently undergoing Phase-III clinical trials for acute coronary syndrome (unstable angina/non-ST segment elevation myocardial infarction) and secondary prevention of cardiovascular events in high-risk patients.
參考文獻(xiàn)	Boyle, J., et al.: Curr. Vasc. Pharmacol., 3, 63 (2005), Jennings, L., et al.: Expert. Opin. Drug Metab. Toxicol., 1, 727 (2005), Chackalamannil, S., et al.: J. Med. Chem., 49, 5389 (2006),

聯(lián)系我們

^{<dl id="ilis8"></dl>}<strike id="ilis8"><option id="ilis8"></option></strike>

<blockquote id="ilis8"></blockquote>